Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases

Clinical article

View More View Less
  • 1 Stich Radiation Oncology;
  • 2 Division of Biostatistics and Epidemiology, Department of Public Health;
  • 3 Department of Radiology; and
  • 4 Department of Neurosurgery, Weill Medical College of Cornell University, New York, New York
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object

Resected brain metastases have a high rate of local recurrence without adjuvant therapy. Adjuvant whole-brain radiotherapy (WBRT) remains the standard of care with a local control rate > 90%. However, WBRT is delivered over 10–15 days, which can delay other therapy and is associated with acute and long-term toxicities. Permanent cesium-131 (131Cs) implants can be used at the time of metastatic resection, thereby avoiding the need for any additional therapy. The authors evaluated the safety, feasibility, and efficacy of a novel therapeutic approach with permanent 131Cs brachytherapy at the resection for brain metastases.

Methods

After institutional review board approval was obtained, 24 patients with a newly diagnosed metastasis to the brain were accrued to a prospective protocol between 2010 and 2012. There were 10 frontal, 7 parietal, 4 cerebellar, 2 occipital, and 1 temporal metastases. Histology included lung cancer (16), breast cancer (2), kidney cancer (2), melanoma (2), colon cancer (1), and cervical cancer (1). Stranded 131Cs seeds were placed as permanent volume implants. The prescription dose was 80 Gy at a 5-mm depth from the resection cavity surface. Distant metastases were treated with stereotactic radiosurgery (SRS) or WBRT, depending on the number of lesions. The primary end point was local (resection cavity) freedom from progression (FFP). Secondary end points included regional FFP, distant FFP, median survival, overall survival (OS), and toxicity.

Results

The median follow-up was 19.3 months (range 12.89–29.57 months). The median age was 65 years (range 45–84 years). The median size of resected tumor was 2.7 cm (range 1.5–5.5 cm), and the median volume of resected tumor was 10.31 cm3 (range 1.77–87.11 cm3). The median number of seeds used was 12 (range 4–35), with a median activity of 3.82 mCi per seed (range 3.31–4.83 mCi) and total activity of 46.91 mCi (range 15.31–130.70 mCi). Local FFP was 100%. There was 1 adjacent leptomeningeal recurrence, resulting in a 1-year regional FFP of 93.8% (95% CI 63.2%–99.1%). One-year distant FFP was 48.4% (95% CI 26.3%–67.4%). Median OS was 9.9 months (95% CI 4.8 months, upper limit not estimated) and 1-year OS was 50.0% (95% CI 29.1%–67.8%). Complications included CSF leak (1), seizure (1), and infection (1). There was no radiation necrosis.

Conclusions

The use of postresection permanent 131Cs brachytherapy implants resulted in no local recurrences and no radiation necrosis. This treatment was safe, well tolerated, and convenient for patients, resulting in a short radiation treatment course, high response rate, and minimal toxicity. These findings merit further study with a multicenter trial.

Abbreviations used in this paper:125I = iodine-125; 131Cs = cesium-131; FFP = freedom from progression; OS = overall survival; QOL = quality of life; RTOG = Radiation Therapy Oncology Group; SRS = stereotactic radiosurgery; WBRT = whole-brain radiotherapy.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address correspondence to: A. Gabriella Wernicke, M.D., M.Sc., Weill Medical College of Cornell University, Stich Radiation Oncology, 525 E. 68th St., New York, NY 10065. email: gaw9008@med.cornell.edu.

Please include this information when citing this paper: published online May 2, 2014; DOI: 10.3171/2014.3.JNS131140.

  • 1

    Aoyama H, , Shirato H, , Onimaru R, , Kagei K, , Ikeda J, & Ishii N, : Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys 56:793800, 2003

    • Search Google Scholar
    • Export Citation
  • 2

    Aoyama H, , Shirato H, , Tago M, , Nakagawa K, , Toyoda T, & Hatano K, : Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:24832491, 2006

    • Search Google Scholar
    • Export Citation
  • 3

    Atalar B, , Choi CY, , Harsh GR IV, , Chang SD, , Gibbs IC, & Adler JR, : Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Neurosurgery 72:180185, 2013

    • Search Google Scholar
    • Export Citation
  • 4

    Beal K, , Chan K, , Chan T, , Yamada Y, , Narayana A, & Lymberis S, : A phase II prospective trial of stereotactic radiosurgery boost following surgical resection for brain metastases. Int J Radiat Oncol Biol Phys 75:Suppl S126S127, 2009. (Abstract)

    • Search Google Scholar
    • Export Citation
  • 5

    Bernstein M, , Cabantog A, , Laperriere N, , Leung P, & Thomason C: Brachytherapy for recurrent single brain metastasis. Can J Neurol Sci 22:1316, 1995

    • Search Google Scholar
    • Export Citation
  • 6

    Blonigen BJ, , Steinmetz RD, , Levin L, , Lamba MA, , Warnick RE, & Breneman JC: Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77:9961001, 2010

    • Search Google Scholar
    • Export Citation
  • 7

    Bogart JA, , Ungureanu C, , Shihadeh E, , Chung TC, , King GA, & Ryu S, : Resection and permanent I-125 brachytherapy without whole brain irradiation for solitary brain metastasis from non-small cell lung carcinoma. J Neurooncol 44:5357, 1999

    • Search Google Scholar
    • Export Citation
  • 8

    Bradley KA, & Mehta MP: Management of brain metastases. Semin Oncol 31:693701, 2004

  • 9

    Chang EL, , Wefel JS, , Hess KR, , Allen PK, , Lang FF, & Kornguth DG, : Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:10371044, 2009

    • Search Google Scholar
    • Export Citation
  • 10

    Chow E, , Davis L, , Holden L, , Tsao M, & Danjoux C: Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage 30:1823, 2005

    • Search Google Scholar
    • Export Citation
  • 11

    Cox JD, , Stetz J, & Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:13411346, 1995

    • Search Google Scholar
    • Export Citation
  • 12

    Crossen JR, , Garwood D, , Glatstein E, & Neuwelt EA: Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12:627642, 1994

    • Search Google Scholar
    • Export Citation
  • 13

    Dagnew E, , Kanski J, , McDermott MW, , Sneed PK, , McPherson C, & Breneman JC, : Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience. Neurosurg Focus 22:3 E3, 2007

    • Search Google Scholar
    • Export Citation
  • 14

    Dale RG, , Jones B, & Coles IP: Effect of tumour shrinkage on the biological effectiveness of permanent brachytherapy implants. Br J Radiol 67:639645, 1994

    • Search Google Scholar
    • Export Citation
  • 15

    DeAngelis LM, , Delattre JY, & Posner JB: Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789796, 1989

  • 16

    Do L, , Pezner R, , Radany E, , Liu A, , Staud C, & Badie B: Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases. Int J Radiat Oncol Biol Phys 73:486491, 2009

    • Search Google Scholar
    • Export Citation
  • 17

    Elaimy AL, , Mackay AR, , Lamoreaux WT, , Fairbanks RK, , Demakas JJ, & Cooke BS, : Clinical outcomes of stereotactic radiosurgery in the treatment of patients with metastatic brain tumors. World Neurosurg 75:673683, 2011

    • Search Google Scholar
    • Export Citation
  • 18

    Gans JH, , Raper DM, , Shah AH, , Bregy A, , Heros D, & Lally BE, : The role of radiosurgery to the tumor bed after resection of brain metastases. Neurosurgery 72:317326, 2013

    • Search Google Scholar
    • Export Citation
  • 19

    Gaspar L, , Scott C, , Rotman M, , Asbell S, , Phillips T, & Wasserman T, : Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745751, 1997

    • Search Google Scholar
    • Export Citation
  • 20

    Gaspar LE, , Scott C, , Murray K, & Curran W: Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47:10011006, 2000

    • Search Google Scholar
    • Export Citation
  • 21

    Hall EJ, & Giaccia AJ: Radiobiology for the Radiologist ed 7 Philadelphia, Lippincott Williams & Wilkins, 2011. 86101

  • 22

    Huang K, , Sneed PK, , Kunwar S, , Kragten A, , Larson DA, & Berger MS, : Surgical resection and permanent iodine-125 brachytherapy for brain metastases. J Neurooncol 91:8393, 2009

    • Search Google Scholar
    • Export Citation
  • 23

    Hwang SW, , Abozed MM, , Hale A, , Eisenberg RL, , Dvorak T, & Yao K, : Adjuvant Gamma Knife radiosurgery following surgical resection of brain metastases: a 9-year retrospective cohort study. J Neurooncol 98:7782, 2010

    • Search Google Scholar
    • Export Citation
  • 24

    Iwai Y, , Yamanaka K, & Yasui T: Boost radiosurgery for treatment of brain metastases after surgical resections. Surg Neurol 69:181186, 2008

    • Search Google Scholar
    • Export Citation
  • 25

    Jagannathan J, , Yen CP, , Ray DK, , Schlesinger D, , Oskouian RJ, & Pouratian N, : Gamma Knife radiosurgery to the surgical cavity following resection of brain metastases. Clinical article. J Neurosurg 111:431438, 2009

    • Search Google Scholar
    • Export Citation
  • 26

    Jarvis LA, , Simmons NE, , Bellerive M, , Erkmen K, , Eskey CJ, & Gladstone DJ, : Tumor bed dynamics after surgical resection of brain metastases: implications for postoperative radiosurgery. Int J Radiat Oncol Biol Phys 84:943948, 2012

    • Search Google Scholar
    • Export Citation
  • 27

    Jensen CA, , Chan MD, , McCoy TP, , Bourland JD, , deGuzman AF, & Ellis TL, : Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. Clinical article. J Neurosurg 114:15851591, 2011

    • Search Google Scholar
    • Export Citation
  • 28

    Kalani MY, , Filippidis AS, , Kalani MA, , Sanai N, , Brachman D, & McBride HL, : Gamma Knife surgery combined with resection for treatment of a single brain metastasis: preliminary results. Clinical article. J Neurosurg 113:Suppl 9096, 2010

    • Search Google Scholar
    • Export Citation
  • 29

    Kalkanis SN, , Kondziolka D, , Gaspar LE, , Burri SH, , Asher AL, & Cobbs CS, : The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:3343, 2010

    • Search Google Scholar
    • Export Citation
  • 30

    Karlovits BJ, , Quigley MR, , Karlovits SM, , Miller L, , Johnson M, & Gayou O, : Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy. Neurosurg Focus 27:6 E7, 2009

    • Search Google Scholar
    • Export Citation
  • 31

    Kelly PJ, , Lin YB, , Yu AY, , Alexander BM, , Hacker F, & Marcus KJ, : Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique. Int J Radiat Oncol Biol Phys 82:95101, 2012

    • Search Google Scholar
    • Export Citation
  • 32

    Kondziolka D, , Niranjan A, , Flickinger JC, & Lunsford LD: Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications. Am J Clin Oncol 28:173179, 2005

    • Search Google Scholar
    • Export Citation
  • 33

    Lazow SP, , Yondorf M, , Kovanlikaya I, , Nori D, , Chao KC, & Boockvar JA, : Temporal changes in MRI edema and resection cavity dynamics subsequent to implantation of cesium-131 (Cs-131) brachytherapy in patients with brain metastases: a volumetric analysis from a prospective study. Int J Radiat Oncol Biol Phys 87:Suppl S256S257, 2013. (Abstract)

    • Search Google Scholar
    • Export Citation
  • 34

    Le Chevalier T, , Smith FP, , Caille P, , Constans JP, & Rouesse JG: Sites of primary malignancies in patients presenting with cerebral metastases. A review of 120 cases. Cancer 56:880882, 1985

    • Search Google Scholar
    • Export Citation
  • 35

    Limbrick DD Jr, , Lusis EA, , Chicoine MR, , Rich KM, , Dacey RG, & Dowling JL, : Combined surgical resection and stereotactic radiosurgery for treatment of cerebral metastases. Surg Neurol 71:280289, 2009

    • Search Google Scholar
    • Export Citation
  • 36

    Ling CC, , Spiro IJ, , Mitchell J, & Stickler R: The variation of OER with dose rate. Int J Radiat Oncol Biol Phys 11:13671373, 1985

  • 37

    Linskey ME, , Andrews DW, , Asher AL, , Burri SH, , Kondziolka D, & Robinson PD, : The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:4568, 2010

    • Search Google Scholar
    • Export Citation
  • 38

    Mathieu D, , Kondziolka D, , Flickinger JC, , Fortin D, , Kenny B, & Michaud K, : Tumor bed radiosurgery after resection of cerebral metastases. Neurosurgery 62:817824, 2008

    • Search Google Scholar
    • Export Citation
  • 39

    McDermott MW, , Cosgrove GR, , Larson DA, , Sneed PK, & Gutin PH: Interstitial brachytherapy for intracranial metastases. Neurosurg Clin N Am 7:485495, 1996

    • Search Google Scholar
    • Export Citation
  • 40

    Minniti G, , Clarke E, , Lanzetta G, , Osti MF, , Trasimeni G, & Bozzao A, : Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48, 2011

    • Search Google Scholar
    • Export Citation
  • 41

    Nieder C, , Schwerdtfeger K, , Steudel WI, & Schnabel K: Patterns of relapse and late toxicity after resection and whole-brain radiotherapy for solitary brain metastases. Strahlenther Onkol 174:275278, 1998

    • Search Google Scholar
    • Export Citation
  • 42

    Ostertag CB, & Kreth FW: Interstitial iodine-125 radiosurgery for cerebral metastases. Br J Neurosurg 9:593603, 1995

  • 43

    Patchell RA: The management of brain metastases. Cancer Treat Rev 29:533540, 2003

  • 44

    Patchell RA, , Tibbs PA, , Regine WF, , Dempsey RJ, , Mohiuddin M, & Kryscio RJ, : Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:14851489, 1998

    • Search Google Scholar
    • Export Citation
  • 45

    Patchell RA, , Tibbs PA, , Walsh JW, , Dempsey RJ, , Maruyama Y, & Kryscio RJ, : A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494500, 1990

    • Search Google Scholar
    • Export Citation
  • 46

    Pieper D, , Suen AW, , Grills IS, , Nandalur S, , Mohammed N, & Mitchell C, : Gamma Knife stereotactic radiosurgery for resected brain metastases. Int J Radiat Oncol Biol Phys 72:Suppl S227S228, 2008. (Abstract)

    • Search Google Scholar
    • Export Citation
  • 47

    Prasad SC, , Bassano DA, , Fear PI, & King GA: Dosimetry of I-125 seeds implanted on the surface of a cavity. Med Dosim 15:217219, 1990

  • 48

    Quigley MR, , Fuhrer R, , Karlovits SM, , Karlovits BJ, & Johnson M: Single session stereotactic radiosurgery boost to the postoperative site in lieu of whole brain radiation in metastatic brain disease. J Neurooncol 87:327332, 2008

    • Search Google Scholar
    • Export Citation
  • 49

    Ravi A, , Keller BM, & Pignol JP: A comparison of postimplant dosimetry for (103)Pd versus (131)Cs seeds on a retrospective series of PBSI patients. Med Phys 38:60466052, 2011

    • Search Google Scholar
    • Export Citation
  • 50

    Rogers LR, , Rock JP, , Sills AK, , Vogelbaum MA, , Suh JH, & Ellis TL, : Results of a phase II trial of the GliaSite Radiation Therapy System for the treatment of newly diagnosed, resected single brain metastases. J Neurosurg 105:375384, 2006

    • Search Google Scholar
    • Export Citation
  • 51

    Schulder M, , Black PM, , Shrieve DC, , Alexander E III, & Loeffler JS: Permanent low-activity iodine-125 implants for cerebral metastases. J Neurooncol 33:213221, 1997

    • Search Google Scholar
    • Export Citation
  • 52

    Schwarz SB, , Thon N, , Nikolajek K, , Niyazi M, , Tonn JC, & Belka C, : Iodine-125 brachytherapy for brain tumours—a review. Radiat Oncol 7:30, 2012

    • Search Google Scholar
    • Export Citation
  • 53

    Shaw E, , Scott C, , Souhami L, , Dinapoli R, , Kline R, & Loeffler J, : Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90–05. Int J Radiat Oncol Biol Phys 47:291298, 2000

    • Search Google Scholar
    • Export Citation
  • 54

    Sheline GE, & Brady LW: Radiation therapy for brain metastases. J Neurooncol 4:219225, 1987

  • 55

    Sneed PK, , Suh JH, , Goetsch SJ, , Sanghavi SN, , Chappell R, & Buatti JM, : A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519526, 2002

    • Search Google Scholar
    • Export Citation
  • 56

    Soltys SG, , Adler JR, , Lipani JD, , Jackson PS, , Choi CY, & Puataweepong P, : Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 70:187193, 2008

    • Search Google Scholar
    • Export Citation
  • 57

    Suh JH, & Barnett GH: Brachytherapy for brain tumor. Hematol Oncol Clin North Am 13:635650, viiiix, 1999

  • 58

    Suwinski R, , Sowa A, , Rutkowski T, , Wydmanski J, , Tarnawski R, & Maciejewski B: Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients. Int J Radiat Oncol Biol Phys 56:399412, 2003

    • Search Google Scholar
    • Export Citation
  • 59

    Weil RJ: Does trastuzumab increase the risk of isolated central nervous system metastases in patients with breast cancer?. Nat Clin Pract Oncol 3:236237, 2006

    • Search Google Scholar
    • Export Citation
  • 60

    Wernicke AG, , Chao KS, , Nori D, , Parashar B, , Yondorf M, & Boockvar JA, : The cost-effectiveness of surgical resection plus cesium-131 (Cs-131) brachytherapy versus stereotactic radiosurgery versus surgery + whole brain radiotherapy (WBRT) versus WBRT in the treatment of metastatic brain tumors. Neuro Oncol 14:Suppl 6 vi139vi141, 2012. (Abstract)

    • Search Google Scholar
    • Export Citation
  • 61

    Yang R, , Wang J, & Zhang H: Dosimetric study of Cs-131, I-125, and Pd-103 seeds for permanent prostate brachytherapy. Cancer Biother Radiopharm 24:701705, 2009

    • Search Google Scholar
    • Export Citation
  • 62

    Yondorf M, , Nedialkova L, , Parashar B, , Nori D, , Chao KC, & Boockvar JA, : Resection cavity dynamics following implantation of cesium-131 (Cs-131) brachytherapy for resection brain metastases based on CT-planning. Int J Radiat Oncol Biol Phys 87:Suppl S161S162, 2013. (Abstract)

    • Search Google Scholar
    • Export Citation
  • 63

    Zamorano L, , Yakar D, , Dujovny M, , Sheehan M, & Kim J: Permanent iodine-125 implant and external beam radiation therapy for the treatment of malignant brain tumors. Stereotact Funct Neurosurg 59:183192, 1992

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 156 156 43
Full Text Views 456 76 1
PDF Downloads 263 67 1
EPUB Downloads 0 0 0